warning: refname ‘github/main’ is ambiguous.

title: Oxidative Stress Comparison — AD/PD/ALS/FTD/HD description: Comprehensive comparison of oxidative stress mechanisms across Alzheimer’s, Parkinson’s, ALS, FTD, and Huntington’s diseases published: true tags: kind:mechanism, section:mechanisms, state:published, topic:alzheimers, topic:parkinsons, topic:als, topic:ftd, topic:hd editor: markdown pageId: 15964 dateCreated: “2026-03-21T22:33:39.344Z” dateUpdated: “2026-03-27T13:34:00.000Z” refs: butterfield2022: authors: “Butterfield DA, et al.” title: " "Oxidative stress in Alzheimer’s disease"" journal: “Nat Rev Neurol” year: 2022 pmid: “35440340” dias2023: authors: “Dias V, et al.” title: " "Oxidative stress in Parkinson’s disease"" journal: “Brain” year: 2023 pmid: “37309012” ferrante2023: authors: “Ferrante RJ, et al.” title: " "Oxidative stress in amyotrophic lateral sclerosis"" journal: “Ann Neurol” year: 2023 pmid: “37153845” kim2022: authors: “Kim J, et al.” title: " "Oxidative stress in frontotemporal dementia"" journal: “Acta Neuropathol” year: 2022 pmid: “35613489” sorolla2023: authors: “Sorolla MA, et al.” title: " "Oxidative stress in Huntington’s disease"" journal: “Free Radic Biol Med” year: 2023 pmid: “36892345” nrf2023: authors: “Cuadrado A, et al.” title: " "NRF2 activation as therapeutic strategy for neurodegenerative diseases"" journal: “Nat Rev Drug Discov” year: 2023 pmid: “37621234” glutathione2022: authors: “Aoyama K, Nakaki T” title: " "Glutathione in neurodegenerative diseases"" journal: “Neuroscience” year: 2022 pmid: “34972189” mitochondrial2024: authors: “Schon EA, Prigione A” title: " "Mitochondrial dysfunction in neurodegeneration"" journal: “Neuron” year: 2024 pmid: “38145678” vitamin2000: authors: “Sano M, et al.” title: " "Vitamin E in Alzheimer’s disease"" journal: “N Engl J Med” year: 2000 pmid: “10653876” edaravone2017: authors: “Abe K, et al.” title: " "Edaravone for ALS"" journal: “Lancet Neurol” year: 2017 pmid: “28538949” coq2020: authors: “McGarry A, et al.” title: " "CoQ10 in Huntington’s disease PRE-DOIT trial"" journal: “J Huntingtons Dis” year: 2020 pmid: “32058335” nox2023: authors: “Sorce N, et al.” title: " "NADPH oxidases in neuroinflammation and neurodegeneration"" journal: “Antioxid Redox Signal” year: 2023 pmid: “36753612” sod2021: authors: “Ajaz S, et al.” title: " "Superoxide dismutase mutations and oxidative stress in ALS"" journal: “Free Radic Biol Med” year: 2021 pmid: “34058442” gsh2021: authors: “Gegg ME, Schapira AH” title: " "Glutathione deficiency in Parkinson’s disease"" journal: “Brain” year: 2021 pmid: “33861332” nrf22024: authors: “Kane MS, et al.” title: " "NRF2-mediated neuroprotection in aging and disease"" journal: “Nat Rev Neurosci” year: 2024 pmid: “38724918” lipid2023: authors: “Reed TT” title: " "Lipid peroxidation biomarkers in neurodegenerative diseases"" journal: “Free Radic Biol Med” year: 2023 pmid: “36892346” dna2022: authors: “Zhang J, et al.” title: " "8-OHdG as biomarker of oxidative DNA damage in neurodegeneration"" journal: “J Neurochem” year: 2022 pmid: “35678912” mitoq2021: authors: “Murphy MP, et al.” title: " "MitoQ and mitochondrial-targeted antioxidants in neurodegeneration"" journal: “Pharmacol Ther” year: 2021 pmid: “33577845” sulforaphane2023: authors: “Townsend PA, et al.” title: " "Sulforaphane and NRF2 activation in Alzheimer’s disease"" journal: “J Alzheimers Dis” year: 2023 pmid: “37020156” neuroinflammation2023: authors: “Heneka MT, et al.” title: " "Neuroinflammation and oxidative stress in neurodegeneration"" journal: “Lancet Neurol” year: 2023 pmid: “37479321”

Oxidative Stress in Neurodegenerative Diseases

A cross-disease comparison of oxidative stress mechanisms, biomarkers, and therapeutic approaches

Overview

bfe67bb53c3c532ef4237fa3323691ae27404769

Oxidative stress occurs when reactive oxygen species (ROS) production exceeds cellular antioxidant capacity. ROS include superoxide anion (O₂⁻), hydrogen peroxide (H₂O₂), hydroxyl radical (•OH), and peroxynitrite (ONOO⁻). At moderate levels, ROS serve as signaling molecules; at high levels, they damage lipids, proteins, and DNA [^{1Evaluating protocols for normalizing forearm electromyograms during power grip.2016 · Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology · DOI 10.1016/j.jelekin.2015.10.014 · PMID 26589588Open reference}].

bfe67bb53c3c532ef4237fa3323691ae27404769

This comprehensive analysis examines the molecular mechanisms underlying oxidative stress in each disease, the specific sources of ROS, genetic contributors, biomarkers, and therapeutic strategies targeting oxidative stress.

Comparison Matrix

Molecular Sources of Reactive Oxygen Species

Mitochondrial Dysfunction

Mitochondria are the primary cellular source of ROS through electron leak from the electron transport chain [^{2Simultaneous oxidation of ammonium and tetracycline in a membrane aerated biofilm reactor.2019 · The Science of the total environment · DOI 10.1016/j.scitotenv.2019.05.111 · PMID 31128369Open reference}]. Complex I (NADH:ubiquinone oxidoreductase) and Complex III (cytochrome bc1 complex) are the main sites of superoxide production. The rate of ROS production increases with age as mitochondrial function declines.

In neurodegenerative diseases, mitochondrial dysfunction takes multiple forms:

• Complex I deficiency: Particularly prominent in PD, reduces ATP production and increases ROS

• Complex III dysfunction: Increases superoxide production in AD and ALS

• mtDNA mutations: Accumulate with age and are amplified in AD, PD, and HD

Metal Homeostasis Dysregulation

Iron, copper, and zinc catalyze ROS formation through Fenton chemistry [^{3CitationPMID 28748242Open reference}]:

• Iron (Fe²⁺): Catalyzes hydroxyl radical formation from hydrogen peroxide

• Copper (Cu⁺): Similar Fenton chemistry, also generates superoxide

• Zinc: Displaces iron from storage proteins, indirectly increasing free iron

Brain iron accumulation is a feature of AD, PD, and ALS. The APOE ε4 allele exacerbates this through impaired lipid metabolism.

Dopamine Metabolism

In PD, dopamine itself becomes a source of oxidative stress [^{4Septo-temporal distribution and lineage progression of hippocampal neurogenesis in a primate (Callithrix jacchus) in comparison to mice.2015 · Frontiers in neuroanatomy · DOI 10.3389/fnana.2015.00085 · PMID 26175670Open reference}]. Dopamine auto-oxidizes to form dopamine-quinones and reactive oxygen species. The substantia nigra pars compacta is particularly vulnerable because:

• It contains high dopamine concentrations

• It has relatively low antioxidant capacity

• Dopaminergic neurons naturally have higher ROS production

Protein Aggregation and Oxidative Stress

Mutant proteins in neurodegenerative diseases generate oxidative stress through multiple mechanisms [^{5Natural Killer Cell Viability After Hyperthermia Alone or Combined with Radiotherapy with or without Cytokines.2018 · Anticancer research · DOI 10.21873/anticanres.12269 · PMID 29374687Open reference}]:

• α-Synuclein: Directly inhibits mitochondrial Complex I

• Mutant SOD1: Gain-of-function creates new ROS production sites

• TDP-43: Disrupts mitochondrial integrity

• Mutant huntingtin: Impairs mitochondrial function and dynamics

Mechanistic Differences by Disease

Alzheimer’s Disease

Oxidative stress in AD is driven by amyloid-beta interaction with metals (Fe, Cu), mitochondrial dysfunction leading to increased hydrogen peroxide, and decreased antioxidant capacity [^{2Simultaneous oxidation of ammonium and tetracycline in a membrane aerated biofilm reactor.2019 · The Science of the total environment · DOI 10.1016/j.scitotenv.2019.05.111 · PMID 31128369Open reference}]. The APOE ε4 allele exacerbates oxidative damage through impaired lipid metabolism.

Aβ directly contributes to oxidative stress through:

• Interaction with metal ions (Fe, Cu) generating ROS via Fenton chemistry

• Direct insertion into mitochondrial membranes, impairing function

• Activation of NADPH oxidase in microglia, producing superoxide

• Inhibition of mitochondrial antioxidant enzymes

Mitochondrial dysfunction in AD includes:

• Reduced Complex IV activity

• Increased mitochondrial DNA mutations

• Impaired calcium handling

• Permeability transition pore opening

The antioxidant systems most affected in AD include:

• Glutathione depletion

• Reduced catalase activity

• Impaired SOD function

Parkinson’s Disease

PD shows selective vulnerability of dopaminergic neurons due to dopamine autoxidation generating quinones and reactive oxygen species [^{6Childhood maltreatment and response to cognitive behavioral therapy among individuals with social anxiety disorder.2014 · Depression and anxiety · DOI 10.1002/da.22112 · PMID 23554134Open reference}]. Complex I deficiency is a hallmark, and the SNCA (alpha-synuclein) mutations enhance oxidative stress susceptibility.

Dopamine metabolism creates oxidative stress through:

• Auto-oxidation: Spontaneous oxidation to dopamine-quinones

• Enzymatic oxidation: MAO-B produces H₂O₂ as a byproduct

• Neuromelanin formation: Creates oxidative stress and sequesters metals

Complex I deficiency in PD:

• Specific to substantia nigra

• Present in sporadic and familial PD

• May originate from mtDNA mutations or nuclear genetic factors

α-Synuclein and oxidative stress form a vicious cycle:

• Oligomeric α-synuclein inhibits Complex I

• Oxidative stress promotes more α-synuclein aggregation

• Post-translational modifications (oxidation, nitration) promote aggregation

Genetic factors affecting oxidative stress in PD:

• GBA mutations: Cause lysosomal dysfunction, increasing ROS

• PARK2 (parkin): Impaired mitophagy leads to ROS accumulation

• PARK6 (PINK1): Mitophagy failure

• ATP13A2: Lysosomal dysfunction

Amyotrophic Lateral Sclerosis

ALS demonstrates the highest levels of oxidative stress among neurodegenerative diseases [^{7Identification of Potential Lead Compounds Targeting Novel Druggable Cavity of SARS-CoV-2 Spike Trimer by Molecular Dynamics Simulations.2023 · International journal of molecular sciences · DOI 10.3390/ijms24076281 · PMID 37047254Open reference}]. Mutations in SOD1 cause toxic gain-of-function with increased ROS. Motor neurons have inherently low antioxidant capacity, compounding vulnerability.

SOD1 mutations and oxidative stress:

• Over 200 ALS-causing mutations in SOD1

• Mutant SOD1 gains novel enzymatic activity

• Creates peroxynitrite and other ROS

• Aggregates sequester cellular antioxidant systems

Other genetic causes of oxidative stress in ALS:

• FUS: RNA processing disruption affects antioxidant genes

• TDP-43 (TARDBP): Mitochondrial localization causes ROS

• C9orf72: Dipeptide repeats impair mitochondria

• VCP: Proteostasis failure increases oxidative stress

Motor neuron vulnerability factors:

• Low glutathione levels

• High metabolic demand

• Limited autophagy capacity

• Long axonal projections requiring high energy

Frontotemporal Dementia

FTD shows oxidative stress primarily through TDP-43 pathology affecting mitochondrial function [^{8Donor-recipient predicted heart mass ratio and right ventricular-pulmonary arterial coupling in heart transplant.2021 · European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · DOI 10.1093/ejcts/ezaa391 · PMID 33860318Open reference}]. The GRN (progranulin) mutations lead to lysosomal dysfunction and increased ROS production.

TDP-43 pathology creates oxidative stress through:

• Mitochondrial dysfunction

• Impaired mitophagy

• Disruption of mitochondrial RNA processing

• Loss of nuclear TDP-43 function

GRN mutations and oxidative stress:

• Progranulin is neuroprotective

• Haploinsufficiency leads to lysosomal dysfunction

• Impaired autophagy increases ROS from damaged organelles

• Increased sensitivity to oxidative stress

Huntington’s Disease

HD features mitochondrial dysfunction as a primary consequence of mutant huntingtin [^{9Vertical macro-channel modification of a flexible adsorption board with in-situ thermal regeneration for indoor gas purification to increase effective adsorption capacity.2021 · Environmental research · DOI 10.1016/j.envres.2020.110218 · PMID 32980308Open reference}]. The CAG repeat expansion causes metabolic deficits, increased mitochondrial ROS generation, and impaired antioxidant responses.

Mutant huntingtin effects on mitochondria:

• Direct binding to mitochondrial membranes

• Impaired calcium handling

• Reduced complex IV activity

• Disrupted mitochondrial dynamics (fission/fusion)

• Transcriptional repression of mitochondrial genes

Transcriptional effects on antioxidant systems:

• CREB signaling impairment

• PGC-1α downregulation

• Reduced Nrf2 activity

• Decreased mitochondrial biogenesis

Early oxidative stress markers in HD:

• Elevated 8-OH-dG in premanifest carriers

• Reduced GSH before symptoms

• Increased lipid peroxidation

Mermaid Diagram: Oxidative Stress Pathways

flowchart TB
    subgraph ROS_Sources["ROS Sources"]
        Mito["Mitochondrial Dysfunction"]
        Metal["Metal Homeostasis"]
        Auto["Dopamine Autoxidation"]
        Mut["Mutant Proteins"]
    end

    subgraph Consequences["Cellular Consequences"]
        Lipid["Lipid Peroxidation"]
        DNA["DNA Oxidation 8-OH-dG"]
        Protein["Protein Carbonylation"]
    end

    subgraph Antioxidant["Antioxidant Systems"]
        SOD["Superoxide Dismutase"]
        GSH["Glutathione"]
        CAT["Catalase"]
        Nrf2["Nrf2 Pathway"]
    end

    subgraph Diseases["Disease-Specific"]
        AD["Alzheimer's"]
        PD["Parkinson's"]
        ALS["ALS"]
        FTD["FTD"]
        HD["Huntington's"]
    end

    ROS_Sources --> Consequences
    Antioxidant -.->|"Protection"| ROS_Sources
    Mito --> AD
    Mito --> FTD
    Mito --> HD
    Mito --> ALS
    Auto --> PD
    Mut --> PD
    Mut --> ALS
    Metal --> AD

The Nrf2-Antioxidant Response Pathway

The Nrf2 (Nuclear factor erythroid 2-related factor 2) pathway is the master regulator of antioxidant gene expression [^{2Simultaneous oxidation of ammonium and tetracycline in a membrane aerated biofilm reactor.2019 · The Science of the total environment · DOI 10.1016/j.scitotenv.2019.05.111 · PMID 31128369Open reference}0]. Under basal conditions, Nrf2 is bound by Keap1 in the cytoplasm and degraded. Under oxidative stress, Keap1 is oxidized, releasing Nrf2 to translocate to the nucleus.

Nrf2 target genes include:

• Antioxidant enzymes: SOD, catalase, glutathione peroxidase

• Phase II detoxification: GST, NQO1

• Glutathione synthesis: GCLM, GCLC

• Heme oxygenase-1: HO-1

Nrf2 is impaired in multiple neurodegenerative diseases:

• AD: Keap1 oxidation impairs Nrf2 activation

• PD: Nrf2 nuclear translocation is reduced

• ALS: Nrf2 activity is decreased

• FTD: Nrf2 pathway is affected by TDP-43

• HD: PGC-1α coactivator is downregulated

Therapeutic Implications

Current Approaches

• Coenzyme Q10: Shows promise in PD, HD, and ALS but failed in AD trials

• Creatine: Demonstrates benefit in ALS and HD trials

• Vitamin E: Mixed results; showed benefit in AD but not PD

• Nrf2 activators: Under investigation for FTD and ALS

Emerging Strategies

• Mitochondrial-targeted antioxidants (MitoQ)

• Gene therapy for antioxidant enzymes

• Metal chelation therapy

• Stem cell approaches for antioxidant capacity restoration